PIII Class A P3 Health Partners Inc. - Class A Common Stock
NASDAQ · Health Care close Oct 2, 2026PIII Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
PIII Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| April 14, 2025 | 1-for-50 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.63 | $-1.93 | 67.4% |
| March 31, 2026 | May 14, 2026 | $0.32 | $-3.58 | 109.0% |
| Dec. 31, 2025 | $-23.02 | $-9.65 | -138.4% | |
| Sept. 30, 2025 | $-9.67 | $-6.16 | -57.0% | |
| June 30, 2025 | $-6.23 | $-4.83 | -28.9% | |
| March 31, 2025 | $-6.28 | $-9.09 | 30.9% | |
| Dec. 31, 2024 | $-19.50 | $-4.18 | -366.3% |
Institutional owners (13F) 22 filers · $3.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 8 (0 vs prior Q) | 4 (+1 vs prior Q) | 4 (+1 vs prior Q) | 5 (+2 vs prior Q) | +79K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| JANE STREET GROUP, LLC | $588,546 | 54,495 | 19.23% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $448,027 | 41,484 | 14.64% | Shares |
| Trinity Financial Advisors LLC | $362,232 | 33,540 | 11.84% | Shares |
| MYDA Advisors LLC | $216,000 | 20,000 | 7.06% | Shares |
| Corient Private Wealth LP | $213,160 | 19,737 | 6.97% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $184,654 | 17,096 | 6.03% | Shares |
| Scientech Research LLC | $176,234 | 16,318 | 5.76% | Shares |
| Abundance Wealth Counselors | $172,800 | 16,000 | 5.65% | Shares |
| VANGUARD GROUP INC | $168,410 | 48,117 | 5.50% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $163,609 | 15,149 | 5.35% | Shares |
| DIVERSIFIED TRUST CO | $145,152 | 13,440 | 4.74% | Shares |
| BlackRock, Inc. | $82,480 | 7,637 | 2.70% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $69,952 | 6,477 | 2.29% | Shares |
| MORGAN STANLEY | $30,457 | 2,820 | 1.00% | Shares |
| UBS Group AG | $25,143 | 2,328 | 0.82% | Shares |
| Tower Research Capital LLC (TRC) | $5,832 | 540 | 0.19% | Shares |
| Vanguard Global Advisers, LLC | $3,326 | 308 | 0.11% | Shares |
| ROYAL BANK OF CANADA | $3,000 | 298 | 0.10% | Shares |
| HRT FINANCIAL LP | $590 | 54,717 | 0.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $389 | 36 | 0.01% | Shares |
| JPMORGAN CHASE & CO | $227 | 19 | 0.01% | Shares |
| Avion Wealth | $0 | 45 | 0.00% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Chicago Pacific Founders UGP, LLC, Chicago Pacific Founders GP, L.P., Chicago Pacific Founders Fund, L.P., Chicago Pacific Founders Fund-A, L.P., Chicago Pacific Founders Fund-B, L.P., VBC Growth SPV, LLC, Chicago Pacific Founders UGP III, LLC, Chicago Pacific Founders GP III, L.P., CPF III PT SPV, LLC, CPF III-A PT SPV, LLC, VBC Growth SPV 3, LLC, VBC Growth SPV 4, LLC ×5 filings | June 6, 2025 | 49.99% | Amendment | · | SEC |
| Leavitt Equity Partners II, L.P., Leavitt Equity Partners II, LLC, Leavitt Equity Partners III, L.P., Leavitt Equity Partners III, LLC, LEP Management, LLC, Leavitt Legacy, LLC, Taylor Leavitt ×3 filings | June 26, 2024 | · | Initial filing | · | SEC |
| NA 2021 GRAT, NA 2021 Trust, NA Charitable Trust, SA 2021 GRAT, SA 2021 Trust, SA Charitable Trust, Abdou Family Trust, Sherif Abdou, M.D., Nahed N. Abdou ×3 filings | Nov. 3, 2023 | · | Initial filing | · | SEC |
| Amir Bacchus, Charlee Co LLC ×3 filings | April 14, 2023 | · | Initial filing | · | SEC |
| Hudson Vegas Investment SPV, LLC, Hudson Vegas Investment Manager, LLC, Straus, Daniel | Dec. 17, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 19 insiders · 7 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Aric Coffman | Title - Chief Executive Officer & President | May 9, 2024 A | · | 0 | 0 | $0 |
| Sherif Abdou | Chief Executive Officer | Jan. 9, 2024 J | 1,608,225 | 0 | 0 | $0 |
| Leif Elliott Pedersen | Chief Financial Officer | May 8, 2026 A | · | 0 | 0 | $0 |
| Atul Kavthekar | Chief Financial Officer | Aug. 2, 2023 A | 768,868 | 0 | 0 | $0 |
| Erin Darakjian | Interim CFO, Senior VP & CAO | Nov. 28, 2022 A | · | 0 | 0 | $0 |
| Eric Atkins | Chief Financial Officer | Dec. 3, 2021 A | 450,517 | 0 | 0 | $0 |
| Amir Bacchus | Chief Medical Officer | Jan. 9, 2024 J | 2,005,193 | 0 | 0 | $0 |
| Thomas Edmunds Price | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Lawrence B. Leisure | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Gregory N. Kazarian | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Jeffrey G Park | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Gregory D Wasson | Director | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
| Robert G Zimmerman | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| Brian R Gamache | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| John R Svoboda | Director | Oct. 4, 2021 C | 25,000 | 0 | 0 | $0 |
| Foresight Sponsor Group, LLC | 10% owner | Oct. 4, 2021 C | 7,526,025 | 0 | 0 | $0 |
| Michael Balkin | 10% owner | Feb. 12, 2021 P | 7,545,264 | 0 | 0 | $0 |
| Mark Thierer | · | Aug. 6, 2025 A | 12,662 | 0 | 0 | $0 |
| Mary A Tolan | · | Aug. 6, 2025 A | 6,331 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 2 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
PIII Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
2 analysts · 2026-09-30Mean target $18.00 +183.0%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.